DrugsIn 2023, 2 novel pharmaceutical agents for small animals were released on the German market: the structural but non-functional analog of the inhibitory neurotransmitter gamma-aminobutyric acid pregabalin with an anxiolytic active component and the dopamine agonist ropinirole in form of eye drops ...
DrugsIn 2023, no new active pharmaceutical ingredients were released on the German market for horses and food-producing animals. Two established veterinary active pharmaceutical ingredients became available for additional species: The phosphorus compound butafosfan was also approved for horses, dogs, and...
byDrugs.com Migraine Treatment The newest novel drug (approved March 9, 2023) for the treatment of migraine is Zavzpret (zavegepant) nasal spray. Migraine Prevention The newest drug (approved September 28, 2021) for the prevention of migraine (episodic migraine) is Qulipta (atogepant). ...
Alzheimer's disease (AD) is the leading cause of dementia, presenting a significant unmet medical need worldwide. The pathogenesis of AD involves various pathophysiological events, including the accumulation of amyloid and tau, neuro-inflammation, and ne
Alzheimer's disease (AD) is the leading cause of dementia, presenting a significant unmet medical need worldwide. The pathogenesis of AD involves various pathophysiological events, including the accumulation of amyloid and tau, neuro-inflammation, and ne
New drugs to prevent oxaliplatin-induced peripheral neuropathy: A double-blind, randomized study.doi:10.1200/JCO.2024.42.16_suppl.35686313568#Background:Postoperative adjuvant chemotherapy for colorectal cancer reduces postoperative recurrence; however, it often causes undesirable adverse events. Oxaliplatin...
Investigational New Drugs is a forum for rapid dissemination of information on new anticancer agents. The journal publishes original articles dealing with ...
About Investigational New Drugs The development of new anticancer agents is one of the most rapidly changing aspects of cancer research. Investigational New Drugs provides a forum for the rapid dissemination of information on new anticancer agents. The papers published are of interest to the medical...
Two new drugs, mirikizumab-mrkz (Omvoh) and etrasimod (Velsipity), have been approved to treat ulcerative colitis in adults.#Both drugs increase the risk of infections and other potentially serious adverse effects.Diane S. AschenbrennerDiane S. Aschenbrenner is a former member of the ...
NCE-1 / Abbreviated New Drug Application acceptance dates for drugs with upcoming New Chemical Entity Exclusivity Expiration dates in 2025 - 2026